UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Clinical cancer research, 2013-09, Vol.19 (17), p.4559-4563

2013

Volltextzugriff (PDF)

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2078-2085

2007

Volltextzugriff (PDF)

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

Clinical cancer research, 2004-11, Vol.10 (22), p.7738-7746

2004

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

Clinical cancer research, 2012-06, Vol.18 (12), p.3212-3217

2012

Volltextzugriff (PDF)

Peptides Inhibitory for the Transcriptional Regulatory Function of Human Papillomavirus E2

Clinical cancer research, 2003-11, Vol.9 (14), p.5423-5428

2003

Volltextzugriff (PDF)

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

JNCI : Journal of the National Cancer Institute, 2000-02, Vol.92 (3), p.225-233

2000

Volltextzugriff (PDF)

Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents

Clinical cancer research, 1996-05, Vol.2 (5), p.799-803

1996

Volltextzugriff (PDF)

High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia

Clinical cancer research, 1995-09, Vol.1 (9), p.1051-1057

1995

Volltextzugriff (PDF)

Expression of Epidermal Growth Factor Receptor and Human Papillomavirus E6/E7 Proteins in Cervical Carcinoma Cells

JNCI : Journal of the National Cancer Institute, 1997-09, Vol.89 (17), p.1271-1276

1997

Volltextzugriff (PDF)

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

Journal of clinical oncology, 1994-04, Vol.12 (4), p.748-758

1994

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management

Journal of clinical oncology, 1995-05, Vol.13 (5), p.1096-1102

1995

Volltextzugriff (PDF)

Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy

Journal of clinical oncology, 1995-03, Vol.13 (3), p.553-559

1995

Volltextzugriff (PDF)

Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function

Cancer research (Chicago, Ill.), 1994-08, Vol.54 (16), p.4448-4453

1994

Volltextzugriff (PDF)

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia

Journal of clinical oncology, 1993-06, Vol.11 (6), p.1055-1061

1993

Volltextzugriff (PDF)

Potential role of bcr-abl in the activation of JAK1 kinase

Clinical cancer research, 1997-02, Vol.3 (2), p.145-149

1997

Volltextzugriff (PDF)

Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas

Clinical cancer research, 1997-02, Vol.3 (2), p.169-177

1997

Volltextzugriff (PDF)

Inactive p53 mutants may enhance the transcriptional activity of wild-type p53

Cancer research (Chicago, Ill.), 1993-10, Vol.53 (20), p.4772-4775

1993

Volltextzugriff (PDF)

Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model

Clinical cancer research, 1997-02, Vol.3 (2), p.281-286

1997

Volltextzugriff (PDF)

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer

Clinical cancer research, 1998-11, Vol.4 (11), p.2717-2721

1998

Volltextzugriff (PDF)

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study

Clinical cancer research, 1998-08, Vol.4 (8), p.1955-1963

1998

Volltextzugriff (PDF)

Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen

JNCI : Journal of the National Cancer Institute, 1989-05, Vol.81 (10), p.790-794

1989

Volltextzugriff (PDF)

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor

Journal of clinical oncology, 1992-03, Vol.10 (3), p.398-405

1992

Volltextzugriff (PDF)

Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1609-1617

1991

Volltextzugriff (PDF)

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas

Journal of immunotherapy, 1991-06, Vol.10 (3), p.207

1991

Volltextzugriff (PDF)

A prospective randomized trial of HLA‐matched versus mismatched single‐donor platelet transfusions in cancer patients

Cancer, 1988-08, Vol.62 (4), p.795-801

1988

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Humans
(26)
Medical Sciences
(25)
Adult
(17)
Female
(17)
Middle Aged
(17)
Male
(14)
Pharmacology. Drug Treatments
(12)
Antineoplastic Agents
(11)
Aged
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Combined Modality Therapy
(8)
Hematologic And Hematopoietic Diseases
(7)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(7)
Tumors
(6)
Adolescent
(5)
Aged, 80 And Over
(5)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

Peptides Inhibitory for the Transcriptional Regulatory Function of Human Papillomavirus E2

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents

High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia

Expression of Epidermal Growth Factor Receptor and Human Papillomavirus E6/E7 Proteins in Cervical Carcinoma Cells

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management

Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy

Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia

Potential role of bcr-abl in the activation of JAK1 kinase

Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas

Inactive p53 mutants may enhance the transcriptional activity of wild-type p53

Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study

Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor

Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas

A prospective randomized trial of HLA‐matched versus mismatched single‐donor platelet transfusions in cancer patients

Aktive Filter

Suchergebnisse filtern